Thomas Finneran news from FierceBiotech
News
Mass. Bio launches ad campaign, ups lobbying
The Massachusetts Biotechnology Council (MBC) has two big projects in the works: it's upping its lobbying spending and at the same time kicking off an ad campaign to boost its profile in the state. Read more...
Mass. Bio members distraught over new controversy
With a fresh controversy swirling around newly appointed Executive Director Robert Coughlin, the Massachusetts Biotechnology Council is being hit with criticism from its own members concerned that Read more...
New Mass. Bio chief caught in fresh controversy
In Massachusetts, the politics of biotechnology is something of a blood sport. The new chief of the state's biotech council, Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets